Impact of early initiation of direct-acting antiviral therapy in thoracic organ transplantation from hepatitis C virus positive donors | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Impact of early initiation of direct-acting antiviral therapy in thoracic organ transplantation from hepatitis C virus positive donors

Smith DE, Chen S, Fargnoli A, et al. Impact of early initiation of direct-acting antiviral therapy in thoracic organ transplantation from hepatitis C virus positive donors. Semin Thorac Cardiovasc Surg. 2021;33(2):407-415.

Publication Type:

Journal Article

Authors:

Smith, DE; Chen, S; Fargnoli, A; et, al

Source:

Semin Thorac Cardiovasc Surg, Volume 33, Issue 2, p.407-415 (2021)

Cited On:

Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors

Export Citation:

RIS Format

Top